Non-small cell lung cancer

You have access
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
MARTIN SVATON, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, LENKA JAKUBIKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MICHAL JIROUSEK, JANA KREJCI, DANIEL KREJCI, ONDREJ BILEK, JIRI BLAZEK, KAROLINA HURDALKOVA, MAGDA BARINOVA and BOHUSLAV MELICHAR

Anticancer Research April 2020, 40 (4) 2209-2217; DOI: https://doi.org/10.21873/anticanres.14182
You have access
Salvage Chemotherapy Following Osimertinib in Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation
MARI TONE, MINORU INOMATA, NOBUYASU AWANO, NAOYUKI KUSE, TATSUNORI JO, HANAKO YOSHIMURA, JONSU MINAMI, KOHEI TAKADA, SHINGO MIYAMOTO and TAKEHIRO IZUMO

Anticancer Research April 2020, 40 (4) 2239-2246; DOI: https://doi.org/10.21873/anticanres.14186
You have access
Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer
TAKAYUKI NAKANO, TETSUHIKO GO, NARIYASU NAKASHIMA, DAGE LIU and HIROYASU YOKOMISE

Anticancer Research February 2020, 40 (2) 1007-1014; DOI: https://doi.org/10.21873/anticanres.14035
You have access
Efficacy of PD-1 Inhibitors in Older Non-small Cell Lung Cancer Patients
YUKIKO NAKAMURA, KAZUHITO MIYAZAKI, NAOTO AIKO, YUKI MISUMI, YOKO AGEMI, YURI TANIGUCHI, MARI ISHI, TSUNEO SHIMOKAWA, HIROAKI OKAMOTO and TAKEHARU YAMANAKA

Anticancer Research February 2020, 40 (2) 923-928; DOI: https://doi.org/10.21873/anticanres.14025
You have access
Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study
SHINICHIRO OKAUCHI, TAKESHI NUMATA, TAKESHI NAWA, HIDEO ICHIMURA, TAKEFUMI SAITO, KENJI HAYASHIHARA, HIDEYASU YAMADA, HIROAKI SATOH, TAKESHI ENDO, YOSHIHISA INAGE, TAKAYUKI KABURAGI, MORIYUKI KIYOSHIMA, YUTAKA YAMADA, TOMOHIRO TAMURA, KAZUHITO SAITO, MASAHARU INAGAKI, NOBUYUKI HIZAWA, YUKIO SATO, TOSHIHIRO SHIOZAWA, IKUO SEKINE, HIROICHI ISHIKAWA, KOICHI KURIHIMA, MITSUAKI SAKAI, KOICHI KAMIYAMA, MASAKI KIMURA, NORIHIRO KIKUCHI, HIROYUKI NAKAMURA, KINYA FURUKAWA, TAKAHIDE KODAMA, KUNIHIKO MIYAZAKI, TAKAAKI YAMASHITA, SHIGEN HAYASHI, YASUNORI FUNAYAMA and AKIHIRO NOMURA

Anticancer Research February 2020, 40 (2) 957-964; DOI: https://doi.org/10.21873/anticanres.14029
You have access
Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions
HYEON-OK JIN, SUNG-EUN HONG, JI-YOUNG KIM, SE-KYEONG JANG, YOUNG-SUN KIM, JU-HEE SIM, AC-CHIN OH, HEYJIN KIM, YOUNG JUN HONG, JIN-KYUNG LEE and IN-CHUL PARK

Anticancer Research December 2019, 39 (12) 6723-6730; DOI: https://doi.org/10.21873/anticanres.13887
You have access
Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer
TSUKASA HASEGAWA, NORIKO YANAGITANI, HIROFUMI UTSUMI, HIROSHI WAKUI, HIROAKI SAKAMOTO, TAKEHIRO TOZUKA, HIROSHI YOSHIDA, YOSHIAKI AMINO, SHINYA UEMATSU, TAKAHIRO YOSHIZAWA, KEN UCHIBORI, SATORU KITAZONO, ATSUSHI HORIIKE, TAKESHI HORAI, KAZUYOSHI KUWANO and MAKOTO NISHIO

Anticancer Research December 2019, 39 (12) 6851-6857; DOI: https://doi.org/10.21873/anticanres.13902
You have access
Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor
MINEHIKO INOMATA, TOMONOBU KADO, SEISUKE OKAZAWA, SHINGO IMANISHI, CHIHIRO TAKA, KENTA KAMBARA, TAKAHIRO HIRAI, HIROAKI TANAKA, KOTARO TOKUI, KANA HAYASHI, TOSHIRO MIWA, RYUJI HAYASHI, SHOKO MATSUI and KAZUYUKI TOBE

Anticancer Research December 2019, 39 (12) 6887-6893; DOI: https://doi.org/10.21873/anticanres.13908
You have access
G3BP1 Depletion Increases Radiosensitisation by Inducing Oxidative Stress in Response to DNA Damage
EUGENE CHO, THOA THI THAN, SU-HYEON KIM, EUN-RAN PARK, MI-YEON KIM, KEE HO LEE and HYUN JIN SHIN

Anticancer Research November 2019, 39 (11) 6087-6095; DOI: https://doi.org/10.21873/anticanres.13816
You have access
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
TOMOMI SANOMACHI, SHUHEI SUZUKI, KEITA TOGASHI, SHIZUKA SEINO, TAKASHI YOSHIOKA, CHIFUMI KITANAKA, MASASHI OKADA and MASAHIRO YAMAMOTO

Anticancer Research September 2019, 39 (9) 4817-4828; DOI: https://doi.org/10.21873/anticanres.13667

Main menu

User menu

Search

Non-small cell lung cancer

Pages